HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 293 filers reported holding HAEMONETICS CORP in Q2 2018. The put-call ratio across all filers is 13.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $417,000 | -58.7% | 6,591 | -65.4% | 0.00% | -33.3% |
Q4 2021 | $1,010,000 | +221.7% | 19,048 | +304.7% | 0.00% | +200.0% |
Q2 2021 | $314,000 | -86.6% | 4,707 | -77.7% | 0.00% | -92.9% |
Q1 2021 | $2,339,000 | +107.4% | 21,072 | +121.9% | 0.01% | +75.0% |
Q4 2020 | $1,128,000 | -53.7% | 9,498 | -65.9% | 0.01% | -75.8% |
Q3 2020 | $2,434,000 | -72.1% | 27,893 | -71.4% | 0.03% | -76.6% |
Q2 2020 | $8,723,000 | +110.3% | 97,393 | +134.0% | 0.14% | +33.0% |
Q1 2020 | $4,148,000 | +103.7% | 41,625 | +134.9% | 0.11% | +783.3% |
Q4 2019 | $2,036,000 | -18.3% | 17,721 | -14.4% | 0.01% | -50.0% |
Q2 2019 | $2,492,000 | +1127.6% | 20,705 | +920.5% | 0.02% | +1100.0% |
Q4 2018 | $203,000 | -95.5% | 2,029 | -96.0% | 0.00% | -96.7% |
Q2 2018 | $4,515,000 | +2102.4% | 50,342 | +1327.7% | 0.06% | +1400.0% |
Q4 2017 | $205,000 | -69.0% | 3,526 | -76.1% | 0.00% | -69.2% |
Q3 2017 | $662,000 | – | 14,754 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AMERICAN CAPITAL MANAGEMENT INC | 736,870 | $31,044,000 | 3.85% |
Black Creek Investment Management Inc. | 555,577 | $23,406,000 | 2.75% |
SNYDER CAPITAL MANAGEMENT L P | 1,294,884 | $54,553,000 | 2.68% |
KESTREL INVESTMENT MANAGEMENT CORP | 452,400 | $19,060,000 | 2.34% |
Van Berkom & Associates Inc. | 907,795 | $38,245,000 | 2.14% |
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 2,059,363 | $86,761,000 | 1.45% |
Champlain Investment Partners, LLC | 1,288,230 | $54,273,000 | 0.96% |
HERMES INVESTMENT MANAGEMENT LTD | 734,973 | $30,964,000 | 0.94% |
Netols Asset Management, Inc. | 146,621 | $6,177,000 | 0.94% |
ANCHOR CAPITAL ADVISORS LLC | 1,112,360 | $46,864,000 | 0.93% |